Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Adherez Issued U.S. Patent for Catenin Molecule Inhibition.
This article is from
The Cancer Letter
archive.
Vol. 29 No. 27 | July 4, 2003
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Senate Confirms Kansas Gov. Sebelius For HHS Secretary
May 1, 2009
TCL Archive
DeVita Heads U.S. Board Of CCCR
August 4, 1989
TCL Archive
Researchers Call For New Approach To Peripheral Neuropathy Testing
February 24, 2012
TCL Archive
NCI-Approved Clinical Trials Listed For Month Of March
April 27, 2001
TCL Archive
H. Lee Moffitt Center Reads The Cancer Letter
July 19, 2002
TCL Archive
In Congress: Senate Passes Bill For DOD Medical Research Funding
August 14, 1998